Stocks · Health care · Biological Products, (No Diagnostic Substances)

Eikon Therapeutics, Inc.

EIKN

United States Fiscal year ends December CIK 0001861123

7.47

-0.40%

Close, 9 Oct 2026 · USD

Alert on the numbers Alert on insider trades

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

7.47 on 9 Oct 2026

2 buys0 sales at will0 planned sales

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
3 Sep 2026	Column Group IV GP, LP 10% owner	Bought	$1.03M	opened
6 Feb 2026	Column Group IV GP, LP 10% owner	Bought	$38.12M	96.5%
4 Feb 2026	Wolfe Josh Director	Bought	$5.00M	opened
4 Feb 2026	Lux Venture Partners V, LLC 10% owner	Bought	$5.00M	opened
4 Feb 2026	FRAZIER KENNETH C Director	Bought	$2.00M	opened
4 Feb 2026	Foresite Capital Management IV, LLC 10% owner	Bought	$999.99K	4.4%